We are live on ! Find out more

2,056 hedge funds and large institutions have $142B invested in Merck in 2018 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 756 increasing their positions, 900 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more first-time investments, than exits

New positions opened: 117 | Existing positions closed: 61

25% more call options, than puts

Call options by funds: $1.4B | Put options by funds: $1.12B

24% more funds holding in top 10

Funds holding in top 10: 115143 (+28)

18% more capital invested

Capital invested by funds: $120B → $142B (+$21.5B)

2% more funds holding

Funds holding: 2,0172,056 (+39)

1.27% more ownership

Funds ownership: 77.38%78.66% (+1.3%)

16% less repeat investments, than reductions

Existing positions increased: 756 | Existing positions reduced: 900

Holders
2,056
Holders Change
+39
Holders Change %
+1.93%
% of All Funds
47.01%
Holding in Top 10
143
Holding in Top 10 Change
+28
Holding in Top 10 Change %
+24.35%
% of All Funds
3.27%
New
117
Increased
756
Reduced
900
Closed
61
Calls
$1.4B
Puts
$1.12B
Net Calls
+$284M
Net Calls Change
+$173M
Name Holding Trade Value Shares
Change
Change in
Stake
Aberdeen Group
101
Aberdeen Group
United Kingdom
$234M -$9.97M -156,543 -4%
Sanders Capital
102
Sanders Capital
Florida
$231M -$21.2M -332,933 -9%
MWNA
103
Marshall Wace North America
New York
$228M +$94M +1,475,797 +78%
USAA
104
United Services Automobile Association
Texas
$228M -$17.7M -278,032 -8%
Russell Investments Group
105
Russell Investments Group
United Kingdom
$218M +$4.33M +67,971 +2%
Canada Life
106
Canada Life
Manitoba, Canada
$213M -$12.4M -194,915 -6%
State of Wisconsin Investment Board
107
State of Wisconsin Investment Board
Wisconsin
$210M -$10.4M -163,294 -5%
Fayez Sarofim & Co
108
Fayez Sarofim & Co
Texas
$208M +$657K +10,307 +0.3%
MAMU
109
Marathon Asset Management (UK)
United Kingdom
$204M +$10.8M +169,857 +6%
M&T Bank
110
M&T Bank
New York
$199M -$4.22M -66,219 -2%
DekaBank Deutsche Girozentrale
111
DekaBank Deutsche Girozentrale
Germany
$196M -$21.9M -343,631 -10%
PAMU
112
Pictet Asset Management (UK)
United Kingdom
$186M -$12M -187,881 -6%
TD Asset Management
113
TD Asset Management
Ontario, Canada
$185M -$6.73M -105,565 -4%
PI
114
PGGM Investments
Netherlands
$182M -$16.7M -262,000 -9%
CIBC Private Wealth Group
115
CIBC Private Wealth Group
Georgia
$177M -$1.25M -19,619 -0.7%
TG
116
TCW Group
California
$176M -$16.8M -264,055 -9%
Robeco Institutional Asset Management
117
Robeco Institutional Asset Management
Netherlands
$173M +$8.75M +137,368 +6%
Mitsubishi UFJ Trust & Banking
118
Mitsubishi UFJ Trust & Banking
Japan
$172M -$232M -3,640,786 -59%
HM
119
HealthCor Management
New York
$171M -$119M -1,860,494 -42%
Thrivent Financial for Lutherans
120
Thrivent Financial for Lutherans
Minnesota
$170M +$4.31M +67,700 +3%
N
121
Natixis
France
$166M +$63.7M +1,000,076 +69%
Citigroup
122
Citigroup
New York
$165M +$3.46M +54,299 +2%
Chevy Chase Trust
123
Chevy Chase Trust
Maryland
$165M -$5.7M -89,538 -4%
National Pension Service
124
National Pension Service
South Korea
$162M -$840K -13,191 -0.5%
LCS
125
Levin Capital Strategies
New York
$155M -$10.3M -161,070 -7%

MRK Hedge Fund Activity: Q3 2018 in Review

2,056 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2018, worth a combined $142B — up 18% from $120B a quarter earlier.

Buyers outnumbered sellers: 117 funds opened new MRK positions and 61 closed out — a net gain of 56 holders — while 756 added to existing stakes and 900 trimmed.

The largest buyer was Capital International Investors, adding an estimated $1.41B. The largest seller was Capital World Investors, cutting an estimated $1.18B.

  • 2,056 institutional investors held Merck (MRK) as of Q3 2018, up from 2,017 in Q2 2018.
  • Funds reported $142B of Merck stock for Q3 2018, up 18% quarter-over-quarter.
  • 117 funds opened new Merck positions in Q3 2018 and 61 closed out, a net change of +56 holders.
  • The largest Merck buyer in Q3 2018 was Capital International Investors, an estimated $1.41B added.
  • The largest Merck seller in Q3 2018 was Capital World Investors, an estimated $1.18B sold.

Based on aggregated 13F filings for Q3 2018.